Specifically, subsets of parathyroid tumors with CDC73 mutations thought to disrupt the nucleolar localization signals might exhibit retained nuclear parafibromin immunoreactivity while evidently displaying negative nucleolar staining—and practicing pathologist should therefore be aware of this staining pattern as well (Fig. 3c) [156]. Here, CDC73 is linked to tumor of parathyroid gland.